Partner With Us
Our partners enable us to invest more funding in direct delivery and drive innovation where it can have the deepest impact.
We work with two kinds of partners — in-kind and impact.
In-kind partners donate their products or services, such as medicine or infrastructure, to keep our costs low.
Impact partners help us build a high-quality integrated model rooted in innovation, technology, and global best practices.
Learn about our current partnerships below, read our FAQs to understand priority areas, and contact us if you’d like to join us.
Nick Simons Foundation
IDEO.org & UKaid
Jasmine Social Investments
Our partnership with Nepal’s government is central to our model. The Ministry of Health is our largest partner by combined value of cash and in-kind support.
We deliver care within the government’s existing infrastructure, leverage their network of community health workers, and receive free pharmaceuticals through their supply chain. Above all, we partner through an innovative performance-based contract, which means we only receive government funding if we deliver results aligned with national healthcare goals.
Our partnership with Watsi enables us to directly crowdfund low-cost, high-impact medical treatments for individual patients. In rural settings, there will always be need to refer some patients to urban specialized care centers to treat complicated conditions.
Building the crowdfunding model with Watsi led us to create a national referral network with nine hospital across the country where we now send patients to get reliable, transparent, and accountable care. See our results.
Brigham and Women’s Hospital
Our partnership with the Brigham and Women’s Hospital in Boston provides us with world-class clinical and public health talent. Several of our team members hold positions at the BWH.
Through BWH’s Division of Global Health Equity, our team members receive salaries, research support, assistance in grant writing and submissions, and access to some of the best global health mentors in the world.